Rukang Zhang

Rukang Zhang

Auto-generated profile, based on publicly available information

Rukang Zhang

Department of Medicine, The University of Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
CCChufan Cai
Chufan Cai
JTJiayi Tu
Jiayi Tu
JNJeronimo Najarro
Jeronimo Najarro
RZRukang Zhang
Rukang Zhang
HFHao Fan
Hao Fan
RWRong Wu
Rong Wu
Calcium homeostasis is critical for cell proliferation, and emerging evidence shows that cancer cells exhibit altered calcium signals to fulfill their need for proliferation. However, it remains unclear whether there are oncogene-specific calcium homeostasis regulations that can expose novel therapeutic targets. Here, from RNAi screen, we report that adenosylhomocysteinase like protein 1 (AHCYL1), a suppressor of the endoplasmic reticulum (ER) calcium channel protein inositol trisphosphate receptor (IP3R), is selectively upregulated and critical for cell proliferation and tumor growth potential of human NRAS-mutated melanoma, but not for melanoma expressing BRAF V600E. Mechanistically, AHCYL1 deficiency results in decreased ER calcium levels, activates the unfolded protein response (UPR), and triggers downstream apoptosis. In addition, we show that AHCYL1 transcription is regulated by activating transcription factor 2 (ATF2) in NRAS-mutated melanoma. Our work provides evidence for oncogene-specific calcium regulations and suggests AHCYL1 as a novel therapeutic target for RAS mutant-expressing human cancers, including melanoma. Implications: Our findings suggest that targeting the AHCYL1–IP3R axis presents a novel therapeutic approach for NRAS-mutated melanomas, with potential applicability to all cancers harboring RAS mutations, such as KRAS-mutated human colorectal cancers.

18 June 2026 in Science
Verified
Journal Article
Closed access
HFHao Fan
Hao Fan
ZZZhong Zheng
Zhong Zheng
KOKaitlyn Oliphant
Kaitlyn Oliphant
JLJiacheng Li
Jiacheng Li
RMRyan Mack
Ryan Mack
JCJing Chen
Jing Chen
How maternal nutrition influences neonatal immune development and imprinting through breastfeeding remains largely unclear. We report that maternal supplementation with trans-vaccenic acid (TVA), the predominant naturally occurring trans-fatty acid in human breast milk, promoted neonatal T cell development in mice. Neonates fed by mothers on a TVA-enriched diet showed an expanded naïve cluster of differentiation 4 (CD4 + ) T cell population and enhanced adaptive immunity against infection. TVA reprogrammed neonatal naïve CD4 + T cells through a G protein–coupled receptor–CCCTC-binding factor axis and promoted T helper cells (Th1)–skewing by cooperating with the transcription factor TBX21. Early-life exposure to maternal TVA via breastfeeding supported long-lasting antiviral immunity in adulthood. Our findings establish the multifaceted benefits of maternal nutrition and breastfeeding via TVA in promoting infant immune homeostasis and protective immunity.

2 April 2024
Verified
Other
Open access
CCChufan Cai
Chufan Cai
JTJiayi Tu
Jiayi Tu
JNJeronimo Najarro
Jeronimo Najarro
RZRukang Zhang
Rukang Zhang
HFHao Fan
Hao Fan
RWRong Wu
Rong Wu
Calcium homeostasis is critical for cell proliferation, and emerging evidence shows that cancer cells exhibit altered calcium signals to fulfill their need for proliferation. However, it remains unclear whether there are oncogene-specific calcium homeostasis regulations that can expose novel therapeutic targets. Here, from RNAi screen, we report that adenosylhomocysteinase like protein 1 (AHCYL1), a suppressor of the endoplasmic reticulum (ER) calcium channel protein inositol trisphosphate receptor (IP3R), is selectively upregulated and critical for cell proliferation and tumor growth potential of human NRAS-mutated melanoma, but not for melanoma expressing BRAF V600E. Mechanistically, AHCYL1 deficiency results in decreased ER calcium levels, activates the unfolded protein response (UPR), and triggers downstream apoptosis. In addition, we show that AHCYL1 transcription is regulated by activating transcription factor 2 (ATF2) in NRAS-mutated melanoma. Our work provides evidence for oncogene-specific calcium regulations and suggests AHCYL1 as a novel therapeutic target for RAS mutant-expressing human cancers, including melanoma.Implications:Our findings suggest that targeting the AHCYL1–IP3R axis presents a novel therapeutic approach for NRAS-mutated melanomas, with potential applicability to all cancers harboring RAS mutations, such as KRAS-mutated human colorectal cancers.

2 April 2024
Verified
Other
Open access
CCChufan Cai
Chufan Cai
JTJiayi Tu
Jiayi Tu
JNJeronimo Najarro
Jeronimo Najarro
RZRukang Zhang
Rukang Zhang
HFHao Fan
Hao Fan
RWRong Wu
Rong Wu
Supplementary Figure 1. AHCYL1 is selectively critical for NRAS-mutated but not for BRAF-mutated human melanoma cells.

2 April 2024
Verified
Other
Open access
CCChufan Cai
Chufan Cai
JTJiayi Tu
Jiayi Tu
JNJeronimo Najarro
Jeronimo Najarro
RZRukang Zhang
Rukang Zhang
HFHao Fan
Hao Fan
RWRong Wu
Rong Wu
Supplementary Figure 2. AHCYL1 knockout selectively causes cell cycle arrest in NRAS-mutant expressing human melanoma cells.

2 April 2024
Verified
Other
Open access
CCChufan Cai
Chufan Cai
JTJiayi Tu
Jiayi Tu
JNJeronimo Najarro
Jeronimo Najarro
RZRukang Zhang
Rukang Zhang
HFHao Fan
Hao Fan
RWRong Wu
Rong Wu
Supplementary Figure 12. AHCYL1 transcription in NRAS-mutated melanoma cells is related to MAPK14.